Royal Bank of Canada
FRTX

Royal Bank of Canada’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Royal Bank of Canada’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6
Closed – – 7814
2023
Q3 		$0 Hold
6
– – ﹤0.01% 7841
2023
Q2 		$0 Hold
6
– – ﹤0.01% 7856
2023
Q1 		$0 Hold
6
– – ﹤0.01% 7678
2022
Q4 		$0 Buy
+6
New +$11 ﹤0.01% 7958
2019
Q3 		– Hold
0
– – – 7255
2019
Q2 		– Hold
0
– – – 7292
2019
Q1 		– Hold
0
– – – 7195
2018
Q4 		– Hold
0
– – – 7243
2018
Q3 		– Hold
0
– – – 7036
2018
Q2 		– Hold
0
– – – 6856
2018
Q1 		– Hold
0
– – – 6922
2017
Q4 		– Hold
0
– – – 7004
2017
Q3 		– Hold
0
– – – 7071
2015
Q3 		– Hold
0
– – – 6835
2015
Q2 		– Hold
0
– – – 6767

Other funds holding FRTX

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Royal Bank of Canada's FRTX Position: Q4 2023 in Review

Royal Bank of Canada sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 6 shares.

Royal Bank of Canada first reported a position in FRTX in Q4 2022 and held it in 4 quarters. The position peaked at $0 in Q3 2023. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.

  • Royal Bank of Canada reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 6 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023.
  • Royal Bank of Canada first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Royal Bank of Canada's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $0 in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.